The RPP Pediatric Dx Panel genetic testing is a multiplex PCR-based diagnostic test that detects the genetic material (DNA or RNA) of multiple respiratory pathogens from a single pediatric sample. Unlike traditional cultures, this advanced molecular testing identifies a wide range of viruses and bacteria—such as RSV, influenza, adenovirus, rhinovirus, and Mycoplasma pneumoniae by amplifying and analyzing their genetic sequences. It provides fast, accurate results within hours, helping clinicians diagnose infections early and tailor treatments precisely. This genetic testing is especially valuable in children, who are more vulnerable to severe respiratory illnesses and may present overlapping symptoms from multiple infections.
Choosing the RPP Pediatric Dx Panel genetic testing ensures rapid, accurate identification of respiratory infections in children, where timely diagnosis is critical. This advanced molecular test can detect multiple pathogens simultaneously from a single swab, reducing the need for multiple tests and minimizing discomfort for young patients. It delivers precise results within hours, helping healthcare providers initiate appropriate treatments quickly, avoid unnecessary antibiotics, and prevent complications or hospitalizations. Especially during peak seasons for flu, RSV, or other outbreaks, this test supports better clinical decisions, infection control, and improved outcomes in pediatric care settings like hospitals, emergency rooms, and outpatient clinics.
This genetic testing is ideal for children showing signs of respiratory illness, especially when the cause is unclear or symptoms are severe. It is also beneficial for children with weakened immune systems, chronic conditions, or those in high-risk environments such as schools or hospitals. Parents and healthcare providers should consider this test to ensure timely diagnosis and appropriate care, reducing the risk of complications and unnecessary treatments.
You should consider this test if:
A healthcare professional collects a sample using a nasopharyngeal swab (inserted gently into the nose) or sometimes a throat swab.
The swab is placed in a special viral transport medium and sent to the laboratory for testing.
In the lab, the genetic material (RNA/DNA) of viruses and bacteria is extracted from the sample.
Using multiplex real-time polymerase chain reaction (RT-PCR), the extracted genetic material is amplified for pathogen detection.
The PCR machine identifies the presence of specific respiratory pathogens by matching genetic markers.
A report is generated with identified pathogens, usually within a few hours.
The healthcare provider reviews the results to determine appropriate treatment or further management.
Our fully integrated E-Lab platform offers online test ordering, real-time tracking, and secure digital reporting bringing convenience and control to both physicians and patients across the country.
From routine blood tests to complex genetic panels, we leverage cutting-edge platforms like NGS, PCR, and AI-powered analytics for maximum accuracy and clinical relevance.
With lab facilities based in Florida, we ensure faster processing times and direct access to our expert team. You get timely results backed by responsive, local customer support.
At E-lab, we are dedicated to innovation, collaboration, and seamless growth.